Quest Diagnostics Introduces Companion Diagnostic for High-Risk Early Breast Cancer
Quest Diagnostics will provide clinical laboratory testing using the Ki-67 IHC MIB-1 pharmDx (Dako Omnis) immunohistochemistry companion diagnostic.
Read More
Search Results for: lung cancer
California’s SB 535 Provides Better Access to Biomarker Testing
California’s SB 535 prohibits insurers that already cover biomarker testing from requiring prior authorization for patients with advanced stage cancer.
Read More
Canines Are Top Dogs vs. Technology in Detecting Prostate Cancer
New research from a team of scientists — and two specially trained dogs — have scientifically validated man’s best friend can “sniff out” prostate cancer.
Read More
OneOncology: NGS Testing Is Backbone of Personalized Treatments
OneOncology and Genentech presented data at a symposium that examined genomic profiling and biomarker testing patterns in community oncology centers.
Read More
What’s Next for Liquid Biopsy Tests?
Foresight Diagnostics CEO and CSO Jake Chabon gives an overview of what’s next for liquid biopsy testing, and how it will impact the continuum of care.
Read More